Latest Carlyle Group Inc. Stock Portfolio
$1.59Billion– No. of Holdings #32
Carlyle Group Inc. Performance:
2024 Q1: -18.68%YTD: -18.68%2023: -10.14%
Performance for 2024 Q1 is -18.68%, and YTD is -18.68%, and 2023 is -10.14%.
About Carlyle Group Inc. and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Carlyle Group Inc. reported an equity portfolio of $1.6 Billions as of 31 Mar, 2024.
The top stock holdings of Carlyle Group Inc. are QDEL, ZI, SLNO. The fund has invested 37.7% of it's portfolio in QUIDELORTHO CORP and 26.5% of portfolio in ZOOMINFO TECHNOLOGIES INC.
The fund managers got completely rid off VERA THERAPEUTICS INC (VERA), JASPER THERAPEUTICS INC (JSPR) and EFFECTOR THERAPEUTICS INC (EFTR) stocks. They significantly reduced their stock positions in ZOOMINFO TECHNOLOGIES INC (ZI) and GETTY IMAGES HOLDINGS INC (GETY). Carlyle Group Inc. opened new stock positions in JASPER THERAPEUTICS INC (JSPR), Q32 BIO INC and KRISPY KREME INC (DNUT). The fund showed a lot of confidence in some stocks as they added substantially to COMPLETE SOLARIA INC, SOLENO THERAPEUTICS INC (SLNO) and ADICET BIO INC (ACET).
The top stock holdings of Carlyle Group Inc. are QDEL, ZI, SLNO. The fund has invested 37.7% of it's portfolio in QUIDELORTHO CORP and 26.5% of portfolio in ZOOMINFO TECHNOLOGIES INC.
The fund managers got completely rid off VERA THERAPEUTICS INC (VERA), JASPER THERAPEUTICS INC (JSPR) and EFFECTOR THERAPEUTICS INC (EFTR) stocks. They significantly reduced their stock positions in ZOOMINFO TECHNOLOGIES INC (ZI) and GETTY IMAGES HOLDINGS INC (GETY). Carlyle Group Inc. opened new stock positions in JASPER THERAPEUTICS INC (JSPR), Q32 BIO INC and KRISPY KREME INC (DNUT). The fund showed a lot of confidence in some stocks as they added substantially to COMPLETE SOLARIA INC, SOLENO THERAPEUTICS INC (SLNO) and ADICET BIO INC (ACET).
Carlyle Group Inc. Equity Portfolio Value
Last Reported on: 03 May, 2024
Carlyle Group Inc. Annual Return Estimates Vs S&P 500
Our best estimate is that Carlyle Group Inc. made a return of -18.68% in the last quarter. In trailing 12 months, it's portfolio return was -28.05%.
New Buys
| Ticker | $ Bought |
|---|---|
| jasper therapeutics inc | 31,303,300 |
| q32 bio inc | 18,073,900 |
| krispy kreme inc | 5,191,300 |
| effector therapeutics inc | 2,721,590 |
| n-able inc | 1,225,080 |
| solarwinds corp | 1,182,940 |
| broadcom inc | 1,000,570 |
| nu hldgs ltd | 863,028 |
New stocks bought by Carlyle Group Inc.
Additions
| Ticker | % Inc. |
|---|---|
| complete solaria inc | 79.78 |
| soleno therapeutics inc | 42.47 |
| adicet bio inc | 39.39 |
Additions to existing portfolio by Carlyle Group Inc.
Reductions
| Ticker | % Reduced |
|---|---|
| zoominfo technologies inc | -25.54 |
| getty images holdings inc | -1.93 |
Carlyle Group Inc. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| vera therapeutics inc | -22,104,400 |
| jasper therapeutics inc | -6,669,550 |
| effector therapeutics inc | -2,228,780 |
Carlyle Group Inc. got rid off the above stocks
Sector Distribution
Carlyle Group Inc. has about 55.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 55.9 |
| Technology | 26.7 |
| Others | 11.8 |
| Communication Services | 2.4 |
| Real Estate | 1.7 |
| Industrials | 1.2 |
Market Cap. Distribution
Carlyle Group Inc. has about 1.1% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 64.9 |
| SMALL-CAP | 21.1 |
| UNALLOCATED | 11.8 |
| LARGE-CAP | 1.1 |
Stocks belong to which Index?
About 7.7% of the stocks held by Carlyle Group Inc. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 92.3 |
| RUSSELL 2000 | 6.6 |
| S&P 500 | 1.1 |
Carlyle Group Inc. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Carlyle Group Inc.
Carlyle Group Inc. has 32 stocks in it's portfolio. About 93.9% of the portfolio is in top 10 stocks. QDEL proved to be the most loss making stock for the portfolio. JSPR was the most profitable stock for Carlyle Group Inc. last quarter.
Last Reported on: 03 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACET | adicet bio inc | 0.44 | 2,948,720 | 6,900,000 | added | 39.39 | ||
| AGLE | spyre therapeutics inc | 0.02 | 9,620 | 364,790 | unchanged | 0.00 | ||
| AIU | meta data limited | 0.01 | 314,400 | 240,610 | unchanged | 0.00 | ||
| AVGO | broadcom inc | 0.06 | 755 | 1,000,570 | new | |||
| CFLT | confluent inc | 0.01 | 7,683 | 234,485 | new | |||
| CUBE | cubesmart | 0.63 | 220,500 | 9,971,010 | unchanged | 0.00 | ||
| DASH | doordash inc | 0.04 | 4,156 | 572,364 | new | |||
| DNUT | krispy kreme inc | 0.33 | 340,748 | 5,191,300 | new | |||
| EFTR | effector therapeutics inc | 0.17 | 192,884 | 2,721,590 | new | |||
| EFTR | effector therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| EM | smart sh global ltd | 0.20 | 4,810,210 | 3,162,230 | unchanged | 0.00 | ||
| GDS | gds hldgs ltd | 1.71 | 4,072,620 | 27,083,000 | unchanged | 0.00 | ||
| GETY | getty images holdings inc | 2.41 | 9,212,800 | 38,233,100 | reduced | -1.93 | ||
| HLVX | hillevax inc | 1.92 | 1,838,490 | 30,500,500 | unchanged | 0.00 | ||
| INVH | invitation homes inc | 1.07 | 477,500 | 17,003,800 | unchanged | 0.00 | ||
| JSPR | jasper therapeutics inc | 1.97 | 1,066,190 | 31,303,300 | new | |||
| JSPR | jasper therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MTEM | molecular templates inc | 0.00 | 13,333 | 28,666 | unchanged | 0.00 | ||
| NABL | n-able inc | 0.08 | 93,732 | 1,225,080 | new | |||
| NCNA | nucana plc | 0.05 | 3,333,330 | 845,333 | unchanged | 0.00 | ||